Stay updated on Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial page.

Latest updates to the Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter updates: added Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision history now includes a new entry for v3.3.2. The previous entry v3.3.1 has been removed from the list.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page history shows a new revision (v3.3.1) replacing v3.2.0, reflecting maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedDeleted the administrative notice about government funding and NIH operating status from the page. This change does not affect study data, results, or navigation.SummaryDifference0.5%

- Check63 days agoChange DetectedThe old and new screenshots show the same record history with identical version entries; only the header and layout differ slightly. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference11%

Stay in the know with updates to Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial page.